MRD / Regn No. : 673 Date : 29/06/2026
Patient Name : Rita Hazra Age & Gender : 72 Yrs. / Female
Contact No. : 9474302683 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (10/Oct/1998) | HYPERTENSION (10/Oct/2010) |
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 112 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 173 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET ROSUVASTATIN 10 MG
STATEZE R 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
2 TABLET TELMISARTAN 40 MG + AMLODIPINE 5 MG
APEL AM 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
3 ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
4 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + METFORMIN 1000 SR
APDA M FORTE 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
5 INJECTION GLARGINE (INJ U100)
BASALOG
Medicine For GLUCOSE CONTROL 		SQ 0-0-58 BEDTIME
 TILL NEXT VISIT
MAY CAUSE LOW BLOOD SUGAR
6 ANTIHYPERGLYCEMIC SEMAGLUTIDE 0.5 MG
SEMATRINITY 0.5 MG 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
7 ESOMEPRAZOLE 40 MG
NEXIUM 		PO 0-0-1 BEFORE DINNER
 6 WEEKS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 29/Dec/2026
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,UACR:SPOT SAMPLE,RETINA CHECK UP
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: